The global Liquid Biopsy Market, valued at US$3.65 billion in 2024 stood at US$4.03 billion in 2025 and is projected to ...

Overview of Circulating Tumor Cells MarketThe Global Circulating Tumor Cells (CTC) Market is a rapidly evolving segment in ...

Liquid biopsy is a new technique that makes it easier to identify and monitor lung cancer without surgery. In India, this ...

Exact Sciences is paying $75 million for exclusive rights to a blood-based "liquid biopsy" screening test from rival firm Freenome ...

PanTracer LBx will strengthen NeoGenomics’ pan-solid tumor CGP portfolio and position it in the growing $3 to $5 billion ...

While the liquid biopsy technology continues to evolve for lung cancer management, researchers are working toward further ...

Liquid biopsy technologies are maturing at a rapid pace. They are already being used as a precision medicine tool, helping clinicians match a patient’s cancer to targeted therapies.

Love & Joy Family Clinic announced an expansion of its screening offerings that strengthens the practice's cancer screenin ...

The researchers also followed a patient for 2.5 years and found that they could detect EML4-ALK in the liquid biopsy a good two months before it was possible to use radiography to confirm the disease.

Liquid biopsy detected targetable mutations in one-third of patients (n = 33) who opted for that test alone.

A patient at Thomas Jefferson University Hospital in Philadelphia has blood drawn for a liquid biopsy last year. The test detected a recurrence of breast cancer. (Jacqueline Larma/AP) ...

The liquid biopsy showed her cancer had developed what’s called resistance to Tarceva, but suggested it might be knocked back by a newer drug called Tagrisso, or osimertinib. It’s another pill.